a biopharmaceutical company, which focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders
Industry Biotechnology
A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with DNLI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then DNLI could also see price increases.
Ticker / NAME | Correlation To NRIX | 1D Price Change % | ||
---|---|---|---|---|
NRIX | 100% | -14.67% | ||
DNLI - NRIX | 46% Loosely correlated | -11.95% | ||
BEAM - NRIX | 45% Loosely correlated | -8.59% | ||
LYEL - NRIX | 44% Loosely correlated | N/A | ||
EDIT - NRIX | 43% Loosely correlated | -3.97% | ||
ALEC - NRIX | 43% Loosely correlated | -17.21% | ||
More |